Vaccines
5 September 2018
Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection4 September 2018
Advaxis Licenses ADXS-HER2 to OS Therapies for Evaluation in the Treatment of Osteosarcoma4 September 2018
Inovio and Korean Partner Dose 1st Subject In Trial to Develop World’s First Vaccine to Prevent Hepatitis C Infection21 August 2018
Initiation of Biosceptre’s Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v21 August 2018
AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer’s Disease and Down Syndrome16 August 2018
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza14 August 2018
Inovio Announces First Patient Dosed in Trial to Determine PENNVAX®-GP’s Ability to Induce Remission of HIV Infection9 August 2018
First Participant Enrolled in BiondVax’s Universal Flu Vaccine Pivotal Phase 3 Clinical Trial8 August 2018
Bavarian Nordic Announces Positive Data from Phase 2 Extension Study of its Universal RSV VaccineNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports